tiprankstipranks
Trending News
More News >

Procept BioRobotics sees FY25 revenue $323M, consensus $321.67M

The Company expects full year 2025 gross margin to be approximately 64.5%. Should global tariff rates remain at current levels, the Company estimates a potential gross margin headwind of approximately $5.0 million, representing a reduction of approximately 150-basis points from our baseline guidance of 64.5%. The majority of this impact is anticipated in the second half of 2025. The Company projects full year 2025 total operating expense of approximately $300.0 million and full year 2025 Adjusted EBITDA loss to be ($35.0) million, both are unchanged from previously issued guidance.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1